Dimensional Fund Advisors’s Alpine Immune Sciences Inc ALPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-191,779
| Closed | -$7.6M | – | 3433 |
|
|
2024
Q1 | $7.6M | Sell |
191,779
-42,102
| -18% | -$1.24M | ﹤0.01% | 2423 |
|
|
2023
Q4 | $4.46M | Buy |
233,881
+66,573
| +40% | +$925K | ﹤0.01% | 2592 |
|
|
2023
Q3 | $1.92M | Buy |
167,308
+25,809
| +18% | +$318K | ﹤0.01% | 2795 |
|
|
2023
Q2 | $1.45M | Buy |
141,499
+1,827
| +1% | +$16.5K | ﹤0.01% | 2859 |
|
|
2023
Q1 | $1.08M | Buy |
139,672
+40,865
| +41% | +$326K | ﹤0.01% | 2887 |
|
|
2022
Q4 | $725 | Buy |
98,807
+47,437
| +92% | +$303K | ﹤0.01% | 2974 |
|
|
2022
Q3 | $370K | Hold |
51,370
| – | – | ﹤0.01% | 3109 |
|
|
2022
Q2 | $437K | Sell |
51,370
-1,694
| -3% | -$14.6K | ﹤0.01% | 3094 |
|
|
2022
Q1 | $476K | Hold |
53,064
| – | – | ﹤0.01% | 3162 |
|
|
2021
Q4 | $735K | Buy |
53,064
+2,700
| +5% | +$33.5K | ﹤0.01% | 3092 |
|
|
2021
Q3 | $538K | Buy |
50,364
+5,064
| +11% | +$46.7K | ﹤0.01% | 3163 |
|
|
2021
Q2 | $408K | Hold |
45,300
| – | – | ﹤0.01% | 3203 |
|
|
2021
Q1 | $480K | Sell |
45,300
-2,854
| -6% | -$35.6K | ﹤0.01% | 3147 |
|
|
2020
Q4 | $607K | Hold |
48,154
| – | – | ﹤0.01% | 3060 |
|
|
2020
Q3 | $423K | Buy |
48,154
+7,600
| +19% | +$69.5K | ﹤0.01% | 3095 |
|
|
2020
Q2 | $394K | Sell |
40,554
-5,443
| -12% | -$23.6K | ﹤0.01% | 3120 |
|
|
2020
Q1 | $132K | Hold |
45,997
| – | – | ﹤0.01% | 3248 |
|
|
2019
Q4 | $177K | Hold |
45,997
| – | – | ﹤0.01% | 3274 |
|
|
2019
Q3 | $180K | Buy |
45,997
+2,485
| +6% | +$10.7K | ﹤0.01% | 3294 |
|
|
2019
Q2 | $183K | Buy |
43,512
+1,845
| +4% | +$10.7K | ﹤0.01% | 3333 |
|
|
2019
Q1 | $286K | Buy |
41,667
+3,578
| +9% | +$22.3K | ﹤0.01% | 3261 |
|
|
2018
Q4 | $140K | Hold |
38,089
| – | – | ﹤0.01% | 3324 |
|
|
2018
Q3 | $241K | Buy |
38,089
+5,270
| +16% | +$36.9K | ﹤0.01% | 3287 |
|
|
2018
Q2 | $248K | Buy |
32,819
+18,052
| +122% | +$149K | ﹤0.01% | 3219 |
|
|
2018
Q1 | $118K | Hold |
14,767
| – | – | ﹤0.01% | 3273 |
|
|
2017
Q4 | $165K | Hold |
14,767
| – | – | ﹤0.01% | 3244 |
|
|
2017
Q3 | $171K | Sell |
14,767
-1
| -0% | -$9 | ﹤0.01% | 3236 |
|
|
2017
Q2 | $142K | Buy |
14,768
+7,474
| +102% | +$71.6K | ﹤0.01% | 3226 |
|
|
2017
Q1 | $85K | Buy |
+7,294
| New | +$73.9K | ﹤0.01% | 3256 |
|
Dimensional Fund Advisors's ALPN Position: Q2 2024 in Review
Dimensional Fund Advisors sold out of Alpine Immune Sciences Inc (ALPN) in Q2 2024, closing a stake of 191,779 shares — an estimated $7.6M sold.
Dimensional Fund Advisors first reported a position in ALPN in Q1 2017 and held it in 29 quarters. The position peaked at $7.6M in Q1 2024. 0 funds tracked by Wall St. Rank hold ALPN as of Q2 2024.
- Dimensional Fund Advisors reported no remaining Alpine Immune Sciences Inc position as of Q2 2024 after selling out during the quarter.
- Dimensional Fund Advisors sold 191,779 Alpine Immune Sciences Inc shares in Q2 2024, an estimated $7.6M.
- Dimensional Fund Advisors first reported a position in Alpine Immune Sciences Inc in Q1 2017 and held it in 29 quarters.
- Dimensional Fund Advisors's Alpine Immune Sciences Inc position peaked at $7.6M in Q1 2024.
- 0 funds tracked by Wall St. Rank held Alpine Immune Sciences Inc as of Q2 2024.
Based on Dimensional Fund Advisors's 13F filing for Q2 2024, filed 9 Aug 2024.